" class="no-js "lang="en-US"> News Archives - Page 255 of 267 - Medtech Alert
Sunday, June 28, 2026

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease | MTA

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Read more

COVID-19

 Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility | Pharmtech Focus

Novavax and Gavi Execute Advance Purchase Agreement for COVID-19 Vaccine for COVAX Facility

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced […]

COVID-19

 Moderna Announces New Supply Agreement with Switzerland for 7 Million Booster Vaccine Doses in 2022 and Option for Additional 7 Million Doses | Pharmtech Focus

Moderna Announces New Supply Agreement with Switzerland for 7 Million Booster Vaccine Doses in 2022 and Option for Additional 7 Million Doses

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]

COVID-19

 Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games | Pharmtech Focus

Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a Memorandum of Understanding […]

Cardiovascular

 Glowing Probe Could Diagnose Cardiovascular Disease Earlier | Pharmtech Focus

Glowing Probe Could Diagnose Cardiovascular Disease Earlier

Researchers have created a probe that glows when it detects an enzyme associated with issues […]

Clinical Trials

 NEJM Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant | Pharmtech Focus

NEJM Publishes Efficacy of Novavax Vaccine Against B.1.351 Variant

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced […]

Drug Development

 FDA Accepts Amgen's Supplemental New Drug Application For Otezla ® (apremilast) For Adults With Mild-To-Moderate Plaque Psoriasis | Pharmtech Focus

FDA Accepts Amgen's sNDA For Otezla ®

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for […]

Industry News

 Bayer Foundation Supports Scientists in Sub-saharan Africa: Collaboration with Alexander Von Humboldt Foundation Expanded | Pharmtech Focus

Bayer Foundation Supports Scientists in Sub-saharan Africa

Bayer Foundation and Alexander von Humboldt Foundation are expanding their existing cooperation. Bayer Foundation provides […]

Diseases

 Roche’s Tecentriq Approved by European Commission as a First-line Monotherapy Treatment for People with a Type of Metastatic Non-small Cell Lung Cancer | Pharmtech Focus

Roche’s Tecentriq Approved by European Commission

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq […]

Manufacturing

 Moderna Announces Expansion of its Manufacturing Technology Center in Massachusetts | Pharmtech Focus

Moderna Expands Manufacturing Technology Center

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today […]

Industry News

 Exelixis Expands Portfolio with Acquisition of GamaMabs AMHR2 | Pharmtech Focus

Exelixis Acquires GamaMabs AMHR2

Exelixis, Inc. (Nasdaq: EXEL) and GamaMabs Pharma SA today announced that they have entered into an […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

    Clinical Trials

     Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS

    Clinical Trials

     Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board

    Appointments

     Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

    News

     Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

    Clinical Trials

     Read more